In particular, based on the current understanding of the mechanisms/mediators underlying kidney disease [33], we studied the renal expression of TGF-β, which is considered the “master regulator” of glomerular and tubulointerstitial fibrosis [34]. This evidence concerns the gene TGFB1 and kidney disorder.